These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22143830)

  • 1. The importance of whole body imaging in tumor-induced osteomalacia.
    Chong WH; Yavuz S; Patel SM; Chen CC; Collins MT
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3599-600. PubMed ID: 22143830
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy.
    Hodgson SF; Clarke BL; Tebben PJ; Mullan BP; Cooney WP; Shives TC
    Endocr Pract; 2006; 12(1):35-42. PubMed ID: 16524861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
    Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic findings and treatment in a 51-year-old woman with oncogenic osteomalacia.
    Lapa C; Genest F; Buck AK; Herrmann K; Kenn W; Rudert M; Jakob F; Seefried L
    J Clin Endocrinol Metab; 2014 Feb; 99(2):385-6. PubMed ID: 24423314
    [No Abstract]   [Full Text] [Related]  

  • 6. Oncogenic osteomalacia related to an intramuscular mesenchymal tumor of the scalene muscles.
    Mennetrey C; D'Journo XB; Burtey S; Taïeb D
    Kidney Int; 2021 Jul; 100(1):245. PubMed ID: 34154714
    [No Abstract]   [Full Text] [Related]  

  • 7. Concordance between whole-body scintigraphy 111In-octreotide and 99mTc-sestamibi uptake in the detection of four tumor-induced osteomalacia cases.
    Ferraz MP; Watanabe T; Sado HN; Ono CR; Buchpiguel CA; Correa PH; Martin RM
    J Clin Endocrinol Metab; 2014 Mar; 99(3):699-700. PubMed ID: 24423352
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Tumour-induced osteomalacia'.
    Munoz J; Michel Ortega R; Celzo F; Donthireddy V
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22736784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
    Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
    Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle(s) in the Haystack-Synchronous Multifocal Tumor-Induced Osteomalacia.
    Annamalai AK; Sampathkumar K; Kane S; Shetty NS; Kulkarni S; Rangarajan V; Purandare N; Pai PS; Mahuvakar AD; Shanthi R; Suriyakumar G; Puri V; Aram S; Gopalakrishnan C; Chelian M; Srinivasan KG; Gill AJ; Gurnell M; Clifton-Bligh R
    J Clin Endocrinol Metab; 2016 Feb; 101(2):390-3. PubMed ID: 26691889
    [No Abstract]   [Full Text] [Related]  

  • 12. A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case.
    Yun KI; Kim DH; Pyo SW
    J Oral Maxillofac Surg; 2009 Feb; 67(2):402-5. PubMed ID: 19138617
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-induced hypophosphatemic osteomalacia as a rare cause of bone pain.
    Spaleniak S; Kade G; Kidziński R; Mazurek A; Lubas A; Niemczyk S
    Pol Arch Intern Med; 2018 Mar; 128(3):189-191. PubMed ID: 29600968
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.
    Gore MO; Welch BJ; Geng W; Kabbani W; Maalouf NM; Zerwekh JE; Moe OW; Sakhaee K
    Kidney Int; 2009 Aug; 76(3):342-7. PubMed ID: 18668025
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-induced osteomalacia originating from the temporal bone: a case report.
    Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
    Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal case of the day. Oncogenic osteomalacia.
    Kaplan PA; Dussault RG; Buchanan PK; Berardo PV; Gizienski TA; Short JG
    AJR Am J Roentgenol; 1996 Jul; 167(1):253, 256-7. PubMed ID: 8659391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Rachitic rosary sign' and 'tie sign' of the sternum in tumour-induced osteomalacia.
    Chakraborty PP; Bhattacharjee R; Mukhopadhyay S; Chowdhury S
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26907825
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteomalacia secondary to osteosarcoma. A case report.
    Cheng CL; Ma J; Wu PC; Mason RS; Posen S
    J Bone Joint Surg Am; 1989 Feb; 71(2):288-92. PubMed ID: 2918014
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-induced osteomalacia (TIO): atypical presentation.
    Khaliq W; Cheripalli P; Tangella K
    South Med J; 2011 May; 104(5):348-50. PubMed ID: 21606715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.